A legacy of innovation
Since our beginning, rheumatology has been a key focus for AbbVie. Our curiosity and dedication remain unyielding as we use cutting-edge science to help improve our understanding of promising new pathways and targets, with the goal of delivering better treatment approaches for patients with rheumatic diseases.
Watch: What’s Hot at EULAR 2020 – Trends and Takeaways:
This year’s EULAR e-Congress looks a little different. To help us pull interesting insights from the virtual-only congress, we asked a few experts to weigh-in. Dr. Janet Pope of University of Western Ontario (UWO) in Canada, and Mudra Kapoor, therapeutic area lead for rheumatology, Global Medical Affairs at AbbVie share their thoughts on how the scientific community is making strides against rheumatoid arthritis and discovering new ways to help more patients achieve remission. Watch the full video (2:30 minutes).